Does the benefit from statin therapy extend beyond 5 years?

Current atherosclerosis reports

Volumn 15, Issue 2, 2013, Pages

  Bulbulia, Richard ^a   Armitage, Jane ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD; CARDIOVASCULAR DISEASE; DRUG EFFECT; HEALTH; HUMAN; METHODOLOGY; MORBIDITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MORBIDITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE; TREATMENT OUTCOME; WORLD HEALTH;

EID: 84879519397     PISSN: None     EISSN: 15346242     Source Type: None    
DOI: 10.1007/s11883-012-0297-1     Document Type: Review

References (0)